• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肠道黏膜屏障在2型糖尿病中的作用及中医干预研究进展]

[Role of Intestinal Mucosal Barrier in Type 2 Diabetes Mellitus and Research Progress in Chinese Medicine Interventions].

作者信息

Yan Cong, Wang Qige, Zhan Libin

机构信息

( 110847) College of Basic Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang 110847, China.

( 110847) Key Laboratory of Ministry of Education for Traditional Chinese Medicine Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, Shenyang 110847, China.

出版信息

Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 May 20;56(3):619-626. doi: 10.12182/20250560107.

DOI:10.12182/20250560107
PMID:40964100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12439637/
Abstract

The intestinal mucosal barrier is closely associated with the occurrence and development of type 2 diabetes mellitus (T2DM). It plays an important role in maintaining the homeostasis of the internal environment and resisting pathogenic invasion by regulating the metabolic homeostasis, immune response, and microbial-host interactions in the human body. According to recent studies, intestinal mucosal barrier dysregulation may constitute a key link in the pathogenesis of T2DM. Herein, we systematically reviewed the mechanisms by which intestinal mucosal barrier damage contributes to the onset of T2DM and the latest advances in modern medical intervention strategies. We also discussed and summarized the latest research findings on using traditional Chinese medicine (TCM) to regulate the intestinal mucosal barrier in the management of T2DM. Currently, the causal relationship and mechanisms linking intestinal mucosal barrier damage to the onset of T2DM remain unclear, and systematic research on the synergistic regulatory mechanisms of approaches integrating TCM and Western medicine is lacking. The approach to manage T2DM through the integration of TCM and Western medicine can provide insights and basis from multiple aspects, such as TCM syndrome differentiation and treatment, balancing drug properties, and multi-targeted therapy. In the future, we should fully leverage the advantages of integrated TCM and Western medicine in treating T2DM and conduct in-depth research focused on the intestinal mucosal barrier, thereby informing evidence-based clinical applications.

摘要

肠道黏膜屏障与2型糖尿病(T2DM)的发生发展密切相关。它在维持内环境稳态以及通过调节人体代谢稳态、免疫反应和微生物 - 宿主相互作用来抵抗病原体入侵方面发挥着重要作用。根据最近的研究,肠道黏膜屏障失调可能是T2DM发病机制中的关键环节。在此,我们系统地综述了肠道黏膜屏障损伤导致T2DM发病的机制以及现代医学干预策略的最新进展。我们还讨论并总结了在T2DM管理中使用中药调节肠道黏膜屏障的最新研究成果。目前,肠道黏膜屏障损伤与T2DM发病之间的因果关系和机制仍不明确,并且缺乏关于中西医结合方法协同调节机制的系统研究。通过中西医结合管理T2DM的方法可以从多个方面提供见解和依据,如中医辨证论治、平衡药物特性和多靶点治疗。未来,我们应充分利用中西医结合治疗T2DM的优势,围绕肠道黏膜屏障开展深入研究,从而为循证临床应用提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7af0/12439637/725bec53e83a/scdxxbyxb-56-3-619-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7af0/12439637/725bec53e83a/scdxxbyxb-56-3-619-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7af0/12439637/725bec53e83a/scdxxbyxb-56-3-619-1.jpg

相似文献

1
[Role of Intestinal Mucosal Barrier in Type 2 Diabetes Mellitus and Research Progress in Chinese Medicine Interventions].[肠道黏膜屏障在2型糖尿病中的作用及中医干预研究进展]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 May 20;56(3):619-626. doi: 10.12182/20250560107.
2
Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.针对代谢紊乱的肠道微生物群靶向疗法:对益生菌发酵草药生物活性成分协同作用的机制洞察
Int J Mol Sci. 2025 Jun 7;26(12):5486. doi: 10.3390/ijms26125486.
3
Alcoholic liver disease: Mechanistic insights and therapeutic potential of traditional Chinese medicine through preclinical and clinical evidence.酒精性肝病:基于临床前和临床证据的中医作用机制见解与治疗潜力
J Ethnopharmacol. 2025 Aug 23;353(Pt B):120465. doi: 10.1016/j.jep.2025.120465.
4
Targeting ferroptosis in the treatment of ulcerative colitis by traditional Chinese medicine: A novel therapeutic strategies.中药靶向铁死亡治疗溃疡性结肠炎:一种新的治疗策略
Phytomedicine. 2025 Apr;139:156539. doi: 10.1016/j.phymed.2025.156539. Epub 2025 Feb 17.
5
Evidence of traditional Chinese medicine for treating type 2 diabetes mellitus: from molecular mechanisms to clinical efficacy.中医药治疗 2 型糖尿病的证据:从分子机制到临床疗效。
Pharm Biol. 2024 Dec;62(1):592-606. doi: 10.1080/13880209.2024.2374794. Epub 2024 Jul 19.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Research progress on the regulation of interstitial cell of Cajal autophagy and apoptosis crosstalk by traditional Chinese medicine in gastrointestinal motility disorders.中药对胃肠动力障碍中Cajal间质细胞自噬与凋亡相互作用调控的研究进展
J Ethnopharmacol. 2025 Jun 11;351:120128. doi: 10.1016/j.jep.2025.120128.
8
Targeting ferroptosis using Chinese herbal compounds to treat respiratory diseases.利用中草药化合物靶向铁死亡治疗呼吸疾病。
Phytomedicine. 2024 Jul 25;130:155738. doi: 10.1016/j.phymed.2024.155738. Epub 2024 Jun 1.
9
Aspects of Genetic Diversity, Host Specificity and Public Health Significance of Single-Celled Intestinal Parasites Commonly Observed in Humans and Mostly Referred to as 'Non-Pathogenic'.人类常见且大多被称为“非致病性”的单细胞肠道寄生虫的遗传多样性、宿主特异性及公共卫生意义
APMIS. 2025 Sep;133(9):e70036. doi: 10.1111/apm.70036.
10
Chinese herbal medicine for oesophageal cancer.用于食管癌的中草药。
Cochrane Database Syst Rev. 2016 Jan 22;2016(1):CD004520. doi: 10.1002/14651858.CD004520.pub7.

本文引用的文献

1
Xiexin Tang restores gut barrier function by regulating the differentiation of CD4 T cells via GPRs and HDACs in T2DM rats.泻心汤通过G蛋白偶联受体(GPRs)和组蛋白去乙酰化酶(HDACs)调节2型糖尿病大鼠CD4 T细胞分化来恢复肠道屏障功能。
J Asian Nat Prod Res. 2025 Sep;27(9):1332-1346. doi: 10.1080/10286020.2025.2459603. Epub 2025 Mar 3.
2
Role of Akkermansia muciniphila in insulin resistance.嗜黏蛋白阿克曼氏菌在胰岛素抵抗中的作用。
J Gastroenterol Hepatol. 2025 Jan;40(1):19-32. doi: 10.1111/jgh.16747. Epub 2024 Oct 13.
3
A core microbiome signature as an indicator of health.
核心微生物组特征作为健康指标。
Cell. 2024 Nov 14;187(23):6550-6565.e11. doi: 10.1016/j.cell.2024.09.019. Epub 2024 Oct 7.
4
Danshen polysaccharides alleviate AFB1 induced Jejunal injury.丹参多糖缓解 AFB1 诱导的空肠损伤。
Ecotoxicol Environ Saf. 2024 Oct 15;285:117115. doi: 10.1016/j.ecoenv.2024.117115. Epub 2024 Sep 28.
5
A host-adapted auxotrophic gut symbiont induces mucosal immunodeficiency.一种宿主适应的营养缺陷型肠道共生菌可诱导黏膜免疫缺陷。
Science. 2024 Sep 27;385(6716):eadk2536. doi: 10.1126/science.adk2536.
6
The characteristic activity of regulatory B cells during the occurrence and development of insulin resistance.调节性B细胞在胰岛素抵抗发生发展过程中的特征性活性。
Endocrine. 2025 Feb;87(2):562-568. doi: 10.1007/s12020-024-04040-7. Epub 2024 Sep 23.
7
Effect of Gegen Qinlian Decoction on the regulation of gut microbiota and metabolites in type II diabetic rats.葛根芩连汤对Ⅱ型糖尿病大鼠肠道微生物群及代谢产物的调节作用
Front Microbiol. 2024 Aug 21;15:1429360. doi: 10.3389/fmicb.2024.1429360. eCollection 2024.
8
Danggui Buxue decoction regulates the immune function and intestinal microbiota of cyclophosphamide induced immunosuppressed mice.当归补血汤对环磷酰胺诱导的免疫抑制小鼠的免疫功能和肠道微生物群具有调节作用。
Front Pharmacol. 2024 Aug 19;15:1420411. doi: 10.3389/fphar.2024.1420411. eCollection 2024.
9
The central role of the gut microbiota in the pathophysiology and management of type 2 diabetes.肠道微生物群在 2 型糖尿病的病理生理学和治疗中的核心作用。
Cell Host Microbe. 2024 Aug 14;32(8):1280-1300. doi: 10.1016/j.chom.2024.07.017.
10
Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation.肠道微生物代谢产物吲哚-3-乙酸通过黏蛋白硫酸盐化维持肠道上皮细胞稳态。
Gut Microbes. 2024 Jan-Dec;16(1):2377576. doi: 10.1080/19490976.2024.2377576. Epub 2024 Jul 27.